Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lakelet Capital is a private equity investment firm focused on lower middle-market companies, primarily supporting ownership transitions, succession situations, and growth initiatives. The firm acquires and invests in profitable private businesses and provides strategic, operational, and financial support through its investment team and affiliated operating resources. Its stated sector interests are broad and include healthcare and healthcare IT among many other industries, but Lakelet itself is not a biotechnology, pharmaceutical, or healthcare operating company. The firm appears to be based in Buffalo, New York and targets businesses in the U.S. and Canada. For a biotech analyst, the key takeaway is that Lakelet Capital is a financial sponsor with multi-sector investment interests rather than a drug developer or healthcare platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lakelet Capital.